Amazon S3 on MSN
WHO supports weight loss drugs for tackling obesity crisis
Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...
The European Medicines Agency (EMA) has recommended extending the use of Mounjaro to younger patients with diabetes, ...
Eli Lilly’s weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market ...
Congress has the power to make obesity treatment and weight management accessible to the communities that need it.
A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be ...
Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...
Eli Lilly leads incretins via Zepbound/Mounjaro, retatrutide at 28.7% loss, $50B R&D and US buildout, 2025 guidance, ...
The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...
Phoenix NP announced a continued rise in patient satisfaction across Arizona, noting that positive feedback has increased as more women seek safe, FDA-approved GLP-1 weight loss medications through ...
The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...
TecFut is one of the hallmarks of Julio Casares’ administration, which in the past five years has regularly invited journalists to personally see the equipment and facilities in Cotia. This year, the ...
TecFut is one of the banners of Julio Casares' management, who has usually invited journalists over the past five years to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results